Prophylactic oseltamivir treatment for prevention of donor-recipient influenza A H1N1 virus transmission does not compromise stem cell mobilization or engraftment

Bone Marrow Transplant. 2011 Feb;46(2):312-3. doi: 10.1038/bmt.2010.97. Epub 2010 May 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Blood Donors*
  • Female
  • Hematopoietic Stem Cell Mobilization*
  • Humans
  • Influenza A Virus, H1N1 Subtype*
  • Influenza, Human / prevention & control*
  • Influenza, Human / transmission
  • Middle Aged
  • Oseltamivir / therapeutic use*
  • Peripheral Blood Stem Cell Transplantation / adverse effects*

Substances

  • Antiviral Agents
  • Oseltamivir